These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 30953802)

  • 1. Immune tolerance of tissue-engineered skin produced with allogeneic or xenogeneic fibroblasts and syngeneic keratinocytes grafted on mice.
    Goyer B; Larouche D; Kim DH; Veillette N; Pruneau V; Bernier V; Auger FA; Germain L
    Acta Biomater; 2019 May; 90():192-204. PubMed ID: 30953802
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Permanent skin replacement using engineered epidermis containing fewer than 5% syngeneic keratinocytes.
    Larochelle F; Ross G; Rouabhia M
    Lab Invest; 1998 Sep; 78(9):1089-99. PubMed ID: 9759653
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Full-thickness skin wound healing using autologous keratinocytes and dermal fibroblasts with fibrin: bilayered versus single-layered substitute.
    Idrus RB; Rameli MA; Low KC; Law JX; Chua KH; Latiff MB; Saim AB
    Adv Skin Wound Care; 2014 Apr; 27(4):171-80. PubMed ID: 24637651
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Allogeneic versus xenogeneic immune reaction to bioengineered skin grafts.
    Erdag G; Morgan JR
    Cell Transplant; 2004; 13(6):701-12. PubMed ID: 15648740
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tissue-engineered skin. Current status in wound healing.
    Bello YM; Falabella AF; Eaglstein WH
    Am J Clin Dermatol; 2001; 2(5):305-13. PubMed ID: 11721649
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autologous and Allogeneic Skin Cell Grafts in the Treatment of Severely Burned Patients: Retrospective Clinical Study.
    Klama-Baryła A; Kitala D; Łabuś W; Kraut M; Glik J; Nowak M; Kawecki M
    Transplant Proc; 2018 Sep; 50(7):2179-2187. PubMed ID: 30177133
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and evaluation of a new composite Laserskin graft.
    Lam PK; Chan ES; To EW; Lau CH; Yen SC; King WW
    J Trauma; 1999 Nov; 47(5):918-22. PubMed ID: 10568722
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Allogeneic fibroblasts used to grow cultured epidermal autografts persist in vivo and sensitize the graft recipient for accelerated second-set rejection.
    Hultman CS; Brinson GM; Siltharm S; deSerres S; Cairns BA; Peterson HD; Meyer AA
    J Trauma; 1996 Jul; 41(1):51-8; discussion 58-60. PubMed ID: 8676424
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro production and transplantation of immunologically active skin equivalents.
    Rouabhia M
    Lab Invest; 1996 Oct; 75(4):503-17. PubMed ID: 8874382
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mixed cultures comprising syngeneic and allogeneic mouse keratinocytes as a graftable skin substitute.
    Suzuki T; Ui K; Shioya N; Ihara S
    Transplantation; 1995 May; 59(9):1236-41. PubMed ID: 7762054
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Permanent skin replacement using chimeric epithelial cultured sheets comprising xenogeneic and syngeneic keratinocytes.
    Rouabhia M
    Transplantation; 1996 May; 61(9):1290-300. PubMed ID: 8629286
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Regenerative medicine: stem cells, cellular and matricial interactions in the reconstruction of skin and cornea by tissue engineering].
    Larouche D; Lavoie A; Proulx S; Paquet C; Carrier P; Beauparlant A; Auger FA; Germain L
    Pathol Biol (Paris); 2009 Jun; 57(4):299-308. PubMed ID: 18513892
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of prolonged tolerance to third-party skin grafts following fully allogeneic bone marrow transplantation in mice.
    Levite M; Reisner Y
    Transplantation; 1993 Mar; 55(3):633-8. PubMed ID: 8456484
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acceptance of allogeneic fibroblasts in skin equivalent transplants.
    Sher SE; Hull BE; Rosen S; Church D; Friedman L; Bell E
    Transplantation; 1983 Nov; 36(5):552-7. PubMed ID: 6356519
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prolonged skin grafts survival time by IFN-γ in allogeneic skin transplantation model during acute rejection through IFN-γ/STAT3/IDO pathway in epidermal layer.
    Zhang Y; Wang Y; Wu G; Zhang W; Wang X; Cai W; Zhang J; Han S; Li Y; Bai X; Shi J; Su L; Hu D
    Biochem Biophys Res Commun; 2018 Feb; 496(2):436-442. PubMed ID: 29288671
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rejection of cultured keratinocyte allografts in presensitized mice.
    Kawai K; Ikarashi Y; Tomiyama K; Matsumoto Y; Fujiwara M
    Transplantation; 1993 Aug; 56(2):265-9. PubMed ID: 8356578
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deep and superficial keloid fibroblasts contribute differentially to tissue phenotype in a novel in vivo model of keloid scar.
    Supp DM; Hahn JM; Glaser K; McFarland KL; Boyce ST
    Plast Reconstr Surg; 2012 Jun; 129(6):1259-1271. PubMed ID: 22634643
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A denatured collagen microfiber scaffold seeded with human fibroblasts and keratinocytes for skin grafting.
    Kempf M; Miyamura Y; Liu PY; Chen AC; Nakamura H; Shimizu H; Tabata Y; Kimble RM; McMillan JR
    Biomaterials; 2011 Jul; 32(21):4782-92. PubMed ID: 21477857
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced CD4 reconstitution by grafting neonatal porcine tissue in alternative locations is associated with donor-specific tolerance and suppression of preexisting xenoreactive T cells.
    Rodriguez-Barbosa JI; Zhao Y; Barth R; Zhao G; Arn JS; Sachs DH; Sykes M
    Transplantation; 2001 Oct; 72(7):1223-31. PubMed ID: 11602846
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Allogeneic skin substitutes applied to burns patients.
    Nanchahal J; Dover R; Otto WR
    Burns; 2002 May; 28(3):254-7. PubMed ID: 11996857
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.